Department of Medicine

September 18, 2013

Fishing for new anti-cancer drugs

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

By Leigh MacMillan
September 5, 2013

Sarcoidosis research finds promising oral therapy

VUMC researchers have reported promising results in using oral antimycobacterial therapy to treat chronic cutaneous sarcoidosis, considered by clinicians a difficult illness to effectively control.

By Wayne Wood
August 22, 2013

Gore, Bernard receive research awards at Faculty Assembly

“Vanderbilt’s Nobel Prize,” the Earl Sutherland Prize for achievement in research, was awarded to John Gore at the Fall Faculty Assembly, while Gordon Bernard received the Thomas Jefferson Award for distinguished service to Vanderbilt.

By VUMC News and Communications
Illustration of human intestinal tract
August 15, 2013

$5.2M NIH grant bolsters colorectal cancer research

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer.

By Bill Snyder
August 15, 2013

Komen grants bolster breast cancer research

Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research.

By VUMC News and Communications
August 15, 2013

Transplant drug added to PREDICT program

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.

By Bill Snyder
August 12, 2013

Noninvasive test detects stomach bug

A noninvasive test can be used to identify the presence of Helicobacter pylori and evaluate its virulence, which will be useful in areas with high rates of H. pylori-associated gastric cancer.
By Leigh MacMillan
July 26, 2013

Reducing fatal rhythms after heart attack

Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.
By Courtney M. Campbell
July 25, 2013

Byrd named president of echocardiography society

Benjamin Byrd III, M.D., professor of Cardiovascular Medicine, has been named president of the 16,000-member American Society of Echocardiography (ASE) for a one-year term following the society’s 24th Annual Scientific Sessions, which were held earlier this month in Minneapolis.
By Kathy Whitney
July 11, 2013

Lovly lands Damon Runyon cancer research award

Christine Lovly, M.D., Ph.D., assistant professor of Medicine, has received the 2013 Damon Runyon Clinical Investigator Award, which supports young physician-scientists conducting patient-oriented cancer research.
By VUMC News and Communications
June 27, 2013

Research effort seeks to improve home care for kidney failure patients

Vanderbilt nephrologist, Thomas Golper, M.D., professor of Medicine in Nephrology and Hypertension, is leading an effort to form a research consortium with a goal of improving care for kidney failure patients who receive a form of home dialysis.
By VUMC News and Communications
June 20, 2013

Correa honored by gastroenterological society

The American Gastroentero-logical Association (AGA) has honored Pelayo Correa, M.D., with its Distinguished Achievement Award, which recognizes an individual for contributions to research that have advanced the science and practice of gastroenterology.
By VUMC News and Communications
June 13, 2013

Clinical Pharmacology celebrates 50th anniversary

Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week.
By Bill Snyder
1 … 106 107 108 109 110 … 123